C3 and COVID-19: Identification of complement activation markers (increased levels of circulating C3a, C5a, and sC5b-9) as well as cellular mitochondrial damage indicators (circulating mtDNA) in COVID-19 patients, as described above, prompted us to look for circulating mortalin in the blood of COVID-19 patients.